Cargando…

Predicting the Development of Gastric Neoplasms in a Healthcare Cohort by Combining Helicobacter pylori Antibodies and Serum Pepsinogen: A 5-Year Longitudinal Study

BACKGROUND: Helicobacter pylori (HP) and gastric atrophy are risk factors for gastric cancer. We evaluated whether the combination of serum HP antibody and pepsinogen (PG), which is indicative of gastric atrophy, could serve as a predictive marker for the development of gastric neoplasms in a Korean...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwak, Min-Sun, Chung, Goh Eun, Chung, Su Jin, Kang, Seung Joo, Yang, Jong In, Kim, Joo Sung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081561/ https://www.ncbi.nlm.nih.gov/pubmed/30140281 http://dx.doi.org/10.1155/2018/8796165

Ejemplares similares

Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance
por: Choi, Saemi, et al.
Publicado: (2019)

Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection
por: Lee, Sun-Young
Publicado: (2016)

Long‐term Effect of Helicobacter pylori Infection on Serum Pepsinogens
por: Kikuchi, Shogo, et al.
Publicado: (2000)

Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening
por: Chen, Xian-Zhe, et al.
Publicado: (2018)

Gastric neoplasms and pepsinogen phenotypes.
por: Ellis, A., et al.
Publicado: (1982)

Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests
por: Hamashima, Chisato, et al.
Publicado: (2017)

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”
por: MIKI, Kazumasa
Publicado: (2011)

Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in Japan
por: Fukuda, Haruhiko, et al.
Publicado: (1995)

Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection
por: Kikuchi, Shogo, et al.
Publicado: (2019)

Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels
por: Eybpoosh, Sana, et al.
Publicado: (2015)

Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort
por: Abnet, C C, et al.
Publicado: (2011)

Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm
por: Cha, Jae Hwang, et al.
Publicado: (2020)

Sero-prevalence of Helicobacter pylori CagA immunoglobulin G antibody, serum pepsinogens and haemoglobin levels in adults
por: Muhsen, Khitam, et al.
Publicado: (2018)

Effect of Smoking on Serum Pepsinogen I Level Depends on Serological Status of Helicobacter pylori
por: Tatemichi, Masayuki, et al.
Publicado: (2001)

Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea
por: Baek, Sung Min, et al.
Publicado: (2020)

Serum Pepsinogen Values in Japanese Junior High School Students With Reference to Helicobacter Pylori Infection
por: Okuda, Masumi, et al.
Publicado: (2020)

Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test
por: Zhou, Jun-peng, et al.
Publicado: (2022)

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2016)

Prediction of true Helicobacter pylori-uninfected status using a combination of age, serum antibody and pepsinogen: Logistic regression analysis
por: Takayama, Takako, et al.
Publicado: (2020)

Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study
Publicado: (2016)

Helicobacter Pylori Infection and Serum Pepsinogen I Concentration in Peptic Ulcer Patients: Effect of Bacterial Eradication
por: Park, Sill Moo, et al.
Publicado: (1996)

Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
por: Kim, Yeon-Ji, et al.
Publicado: (2020)

Prediction of Gastric Cancer Development by Serum Pepsinogen Test and Helicobacter pylori Seropositivity in Eastern Asians: A Systematic Review and Meta-Analysis
por: Terasawa, Teruhiko, et al.
Publicado: (2014)

Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study
por: Leja, Marcis, et al.
Publicado: (2017)

Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia
por: Shin, Seung Hwan, et al.
Publicado: (2015)

Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects
por: Yu, Hong, et al.
Publicado: (2021)

Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups.
por: Knight, T., et al.
Publicado: (1996)

New monoclonal antibody-based test for Helicobacter pylori urease in gastric tissue
por: Kim, Do Hyun, et al.
Publicado: (2016)

Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study
por: Muhsen, Khitam, et al.
Publicado: (2019)

Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens
por: Shimoyama, Tadashi, et al.
Publicado: (2017)

Serum Pepsinogen Values and Helicobacter pylori Status among Control Subjects of a Nested Case-Control Study in the JACC study
por: Kikuchi, Shogo, et al.
Publicado: (2005)

Serum Helicobacter pylori FliD antibody and the risk of gastric cancer
por: Li, Hailin, et al.
Publicado: (2016)

Detection of Helicobacter pylori in Gastric Aspirates Using a Monoclonal Antibody-Based Test
por: Kim, Ho Dong, et al.
Publicado: (2013)

Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area
por: Yuan, Lin, et al.
Publicado: (2020)

Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
por: Re, Valli De, et al.
Publicado: (2021)

Helicobacter pylori Eradication Reduces the Metachronous Recurrence of Gastric Neoplasms by Attenuating the Precancerous Process
por: Jung, Da Hyun, et al.
Publicado: (2015)

Helicobacter pylori Infection with Atrophic Gastritis Is an Independent Risk Factor for Advanced Colonic Neoplasm
por: Lee, Ji Young, et al.
Publicado: (2016)

The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case–control study in Korea
por: Cho, Jun-Hyung, et al.
Publicado: (2017)

Association between Gastric Cancer Risk and Serum Helicobacter pylori Antibody Titers
por: Shuto, Mitsutaka, et al.
Publicado: (2017)

The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer
por: Juan Cai, Wei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tnpegc86e59pcni22mrjlqiepq